ERNA Ernexa Therapeutics Inc.
Healthcare · Market cap: $2.7M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $2.9M | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $2.5M | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $0 | $0 |
| 2026-Q4 | $0 | $0 |
Bought$5.4M5 buy days
Sold$00 sell days
Net insider flow+$5.4Mnet buying · 5 years
Latest trade2025-06-09Cherington Charles
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2025-06-09 | Buy | Cherington Charles | 10% owner | 21,241,163 | $0.10 | $2.1M | 1 |
| 2025-04-02 | Buy | Cherington Charles | 10% owner | 3,768,397 | $0.10 | $376.8K | 1 |
| 2022-12-02 | Buy | HALPERN JOHN D | 10% owner | 335,920 | $3.28 | $1.1M | 1 |
| 2022-12-02 | Buy | Singer Nicholas Jason | Director | 283,286 | $3.28 | $929.2K | 2 |
| 2022-12-02 | Buy | Cherington Charles | Director | 261,756 | $3.28 | $858.6K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Cherington Charles | 10% owner | $3.4M | $0 | 2025-06-09 |
| HALPERN JOHN D | 10% owner | $1.1M | $0 | 2022-12-02 |
| Singer Nicholas Jason | Director | $929.2K | $0 | 2022-12-02 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2022-12-02 | 3 | $2.9M | 61 | -20.6% (-21.1% raw) | -26.3% (-27.8% raw) | -62.0% (-57.5% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.